Glycoprotein inhibitors have been shown to reduce the risk of death, a second heart attack, or the need for revascularization by 48% to 52% in patients who have suffered a… [ Get More Details ]
A year-long study of patients with congestive heart failure found that increased use of medicines increased pharmaceutical costs by 60%; however, hospital costs declined by 78%, producing a net savings… [ Get More Details ]
If all forms of cardiovascular disease were eliminated, life expectancy would rise by almost 7 years.
[ Get More Details ]
Stroke risk reduction from thrombin inhibitor in AFib patients
A recently approved direct thrombin inhibitor was found to reduce the risk of stroke/peripheral embolic events in atrial fibrillation patients by 34%, and the risk of hemorrhagic stroke by 74%—compared… [ Get More Details ]